Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Critical role of microRNA-155 in herpes simplex encephalitis.

Bhela S, Mulik S, Reddy PB, Richardson RL, Gimenez F, Rajasagi NK, Veiga-Parga T, Osmand AP, Rouse BT.

J Immunol. 2014 Mar 15;192(6):2734-43. doi: 10.4049/jimmunol.1302326. Epub 2014 Feb 10.

2.

The dual role of CD8+ T lymphocytes in the development of stress-induced herpes simplex encephalitis.

Anglen CS, Truckenmiller ME, Schell TD, Bonneau RH.

J Neuroimmunol. 2003 Jul;140(1-2):13-27.

PMID:
12864968
3.

Genome-wide mouse mutagenesis reveals CD45-mediated T cell function as critical in protective immunity to HSV-1.

Caignard G, Leiva-Torres GA, Leney-Greene M, Charbonneau B, Dumaine A, Fodil-Cornu N, Pyzik M, Cingolani P, Schwartzentruber J, Dupaul-Chicoine J, Guo H, Saleh M, Veillette A, Lathrop M, Blanchette M, Majewski J, Pearson A, Vidal SM.

PLoS Pathog. 2013 Sep;9(9):e1003637. doi: 10.1371/journal.ppat.1003637. Epub 2013 Sep 12.

4.

Modulation of microglia and CD8(+) T cell activation during the development of stress-induced herpes simplex virus type-1 encephalitis.

Nair A, Hunzeker J, Bonneau RH.

Brain Behav Immun. 2007 Aug;21(6):791-806. Epub 2007 Mar 8.

PMID:
17349776
6.

The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis.

Lundberg P, Ramakrishna C, Brown J, Tyszka JM, Hamamura M, Hinton DR, Kovats S, Nalcioglu O, Weinberg K, Openshaw H, Cantin EM.

J Virol. 2008 Jul;82(14):7078-88. doi: 10.1128/JVI.00619-08. Epub 2008 May 14.

7.

[Diagnostic and therapeutic strategy for acyclovir-resistant herpes encephalitis].

Saijo M.

Rinsho Shinkeigaku. 2014;54(12):1024-7. doi: 10.5692/clinicalneurol.54.1024. Review. Japanese.

PMID:
25672698
9.

Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSV.

Kopp SJ, Ranaivo HR, Wilcox DR, Karaba AH, Wainwright MS, Muller WJ.

Pediatr Res. 2014 Dec;76(6):528-34. doi: 10.1038/pr.2014.135. Epub 2014 Sep 8.

10.

[Genetic susceptibility to herpes simplex encephalitis].

Rozenberg F.

Pathol Biol (Paris). 2013 Jan;61(1):21-7. doi: 10.1016/j.patbio.2013.01.001. Epub 2013 Feb 8. Review. French.

PMID:
23399415
11.
12.
13.
14.

Herpes simplex encephalitis : from virus to therapy.

Rozenberg F, Deback C, Agut H.

Infect Disord Drug Targets. 2011 Jun;11(3):235-50. Review.

PMID:
21488834
15.

Effects of CXCR3 signaling on development of fatal encephalitis and corneal and periocular skin disease in HSV-infected mice are mouse-strain dependent.

Lundberg P, Openshaw H, Wang M, Yang HJ, Cantin E.

Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4162-70.

PMID:
17724202
16.

Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis.

Ramakrishna C, Newo AN, Shen YW, Cantin E.

PLoS Pathog. 2011 Jun;7(6):e1002071. doi: 10.1371/journal.ppat.1002071. Epub 2011 Jun 2.

17.

Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.

Matundan H, Mott KR, Ghiasi H.

J Virol. 2014 Jul;88(14):8016-27. doi: 10.1128/JVI.00913-14. Epub 2014 May 7.

18.

CD8(+) T-cell attenuation of cutaneous herpes simplex virus infection reduces the average viral copy number of the ensuing latent infection.

Wakim LM, Jones CM, Gebhardt T, Preston CM, Carbone FR.

Immunol Cell Biol. 2008 Nov-Dec;86(8):666-75. doi: 10.1038/icb.2008.47. Epub 2008 Jul 8.

PMID:
18607387
19.

Favorable effects of MMP-9 knockdown in murine herpes simplex encephalitis using small interfering RNA.

Zhou Y, Lu ZN, Guo YJ, Mei YW.

Neurol Res. 2010 Oct;32(8):801-9. doi: 10.1179/016164110X12644252260556. Epub 2010 May 18.

PMID:
20483026
20.

In vivo visualization of encephalitic lesions in herpes simplex virus type 1 (HSV-1) infected mice by magnetic resonance imaging (MRI).

Hafezi W, Hoerr V.

Methods Mol Biol. 2013;1064:253-65. doi: 10.1007/978-1-62703-601-6_18.

PMID:
23996263

Supplemental Content

Support Center